Dengue is the most widespread arbovirus infection and poses a serious health and economic issue in tropical and subtropical countries. Currently no licensed vaccine or compounds can be used to prevent or manage the severity of dengue virus (DENV) infection. Honokiol, a lignan biphenol derived from the Magnolia tree, is commonly used in Eastern medicine. Here we report that honokiol has profound antiviral activity against serotype 2 DENV (DENV-2). In addition to inhibiting the intracellular DENV-2 replicon, honokiol was shown to suppress the replication of DENV-2 in baby hamster kidney (BHK) and human hepatocarcinoma Huh7 cells. At the maximum non-toxic dose of honokiol treatment, the production of infectious DENV particles was reduced >90

作者：Chih-Yeu, Fang；Siang-Jyun, Chen；Huey-Nan, Wu；Yueh-Hsin, Ping；Ching-Yen, Lin；David, Shiuan；Chi-Long, Chen；Ying-Ray, Lee；Kao-Jean, Huang

来源：Viruses 2015 年 7卷 9期